Latest Breaking News On - Dupilumab dupixent - Page 3 : comparemela.com

September MIMS Update

September MIMS Update
ajp.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajp.com.au Daily Mail and Mail on Sunday newspapers.

Dupilumab-dupixent
New-indications-dapagliflozin

Symptoms resolve with dupilumab in patients with drug reactions

Symptoms resolve with dupilumab in patients with drug reactions
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Sanofi-genzyme-regeneron
Dupilumab-dupixent
Nicholas-gulati
Clinical-immunology
Icahn-school
Mount-sinai

Bullous Pemphigoid Drug Pipeline Research Report 2023:

Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) The "Bullous pemphigoid - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's.

Dublin
Ireland
Japan
Dupilumab-dupixent
Regeneron-sanofi
Route-of-administration
Astrazeneca
Emerging-drugs
Research-and-markets
Ullous-pemphigoid-drug
Ullous-pemphigoid-pipeline
Ullous-pemphigoid-therapeutic

Dupilumab Is the First Investigational Biologic to Significantly Improve Lung Function in Patients With COPD

The treatment improved lung function at 12 weeks and quality of life at 4 weeks.

United-states
American
Surya-bhatt
Dupilumab-dupixent
International-conference
University-of-alabama
Birmingham-division-of-pulmonary
American-thoracic-society
Thoracic-society
New-england-journal
Birmingham-division
Critical-care-medicine

Evan Dellon, MD, MPH: A Reduction in Dysphagia for EoE Patients

Dupilumab became the first approved treatment for eosinophilic esophagitis in 2022.

Chicago
Illinois
United-states
Evans-dellon
Dupilumab-dupixent
Drug-administration
University-of-north-carolina-school-medicine
Disease-week
Adjunct-professor
Esophageal-diseases
North-carolina-school